Abstract
Direct thrombin inhibitors (DTI) are emerging as alternative anticoagulants to unfractionated heparin and indirect thrombin inhibitors in patients undergoing percutaneous coronary intervention (PCI). We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI.
Original language | English |
---|---|
Pages (from-to) | 270-279 |
Number of pages | 10 |
Journal | Journal of Cardiovascular Pharmacology |
Volume | 45 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2005 |
Externally published | Yes |
Keywords
- Angioplasty
- Bivalirudin
- Percutaneous coronary intervention